Nasdaq Dtil News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq dtil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Dtil Today - Breaking & Trending Today
HC Wainwright reissued their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $60.00 target price on the stock. Precision BioSciences Stock Down 9.1 % Shares of NASDAQ:DTIL opened at $9.74 on Wednesday. The stock has a market cap […] ....
Precision BioSciences, Inc. (NASDAQ:DTIL – Free Report) shares are going to reverse split on Wednesday, February 14th. The 1-30 reverse split was announced on Wednesday, February 14th. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, February 14th. Precision BioSciences Trading Down 4.0 % Shares of DTIL traded […] ....
Precision BioSciences (NASDAQ:DTIL – Get Free Report) is scheduled to release its earnings data before the market opens on Tuesday, November 7th. Analysts expect Precision BioSciences to post earnings of ($0.20) per share for the quarter. Precision BioSciences (NASDAQ:DTIL – Get Free Report) last released its quarterly earnings data on Friday, August 4th. The company […] ....
Precision BioSciences (NASDAQ:DTIL – Get Free Report) and Gritstone bio (NASDAQ:GRTS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership. Risk and Volatility Precision BioSciences has a […] ....
Precision BioSciences (NASDAQ:DTIL – Free Report) had its price target lowered by HC Wainwright from $5.00 to $3.00 in a report released on Thursday, MarketBeat reports. The brokerage currently has a buy rating on the stock. Separately, BTIG Research cut their target price on Precision BioSciences from $6.00 to $2.00 and set a buy rating […] ....